文献速递病毒性肝炎细菌感染、耐药与抗菌药物

美国出生人群乙肝感染率趋势:2001-2018年NHANES数据

Trends in Prevalence and Characteristics of Resolved and Current Hepatitis B Among US-Born Persons: National Health and Nutrition Examination Survey, 2001-2018.
PubMed 文献 · J Infect Dis · 2021-01-01

研究利用2001-2018年美国国家健康与营养调查数据,分析美国出生人群乙肝核心抗体(anti-HBc)阳性率变化。anti-HBc阳性率从2001-2006年的3.5%降至2007-2012年的2.5%,2013-2018年为2.6%。

要点

  • 美国出生人群anti-HBc阳性率近十余年趋于平稳,约2.6%。

核心结论

  • 美国出生人群anti-HBc阳性率在2013-2018年保持平稳,但注射吸毒者中阳性率近翻倍,与急性乙肝监测中特定亚人群发病率上升一致。

研究设计与样本

  • 基于2001-2018年美国国家健康与营养调查(NHANES)数据的横断面分析,纳入美国出生者,分三个时期(2001-2006、2007-2012、2013-2018)比较anti-HBc阳性率。

主要发现

  • 2001-2006、2007-2012、2013-2018年anti-HBc阳性率分别为3.5%、2.5%、2.6%。

临床怎么用

  • 临床应关注美国出生人群中的乙肝感染,尤其对报告注射吸毒史者加强筛查与预防。
  • anti-HBc阳性率平稳但注射吸毒者中上升,提示需在相关亚群强化乙肝疫苗接种和减少伤害干预。

局限性

  • NHANES为横断面调查,无法确定感染时间及因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: After decades of decline, US acute hepatitis B incidence flattened since 2011. In persons aged ≥40 years and in jurisdictions affected by the opioid crisis, there is an increase in new cases. Data suggest new infections are occurring among US-born persons. METHODS: We used National Health and Nutrition Examination Survey data during 2001-2018 to examine changes in total antibody to hepatitis B virus core antigen (anti-HBc) prevalence in US-born persons. During 2013-2018, the distribution of characteristics was examined. RESULTS: During 2001-2006, 2007-2012, and 2013-2018, anti-HBc prevalence was 3.5%, 2.5%, and 2.6% among US-born persons, respectively. This corresponded to 5.7 (range, 4.8-6.6) million US-born persons with resolved or current HBV infection during 2013-2018, including 344 600 persons aged 6-29 years. The largest increase and highest prevalence was among persons who reported injection drug use (IDU), which increased from 35.3% during 2001-2006 to 58.4% during 2013-2018 (P = .07). CONCLUSIONS: Anti-HBc prevalence among US-born persons remained flat during the most recent period, coinciding with a doubling of prevalence among persons reporting IDU. These data are consistent with acute hepatitis B surveillance trends, showing increasing incidence in subpopulations where prevention could be strengthened.Anti-HBc prevalence among US-born persons decreased from 2001-2006 to 2007-2012 and remained flat during 2013-2018, coinciding with a near doubling of prevalence among US-born persons reporting a history of injection drug use.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Ly KN, Xing J, Spradling PR, et al. Trends in Prevalence and Characteristics of Resolved and Current Hepatitis B Among US-Born Persons: National Health and Nutrition Examination Survey, 2001-2018. J Infect Dis. 2021. PMID: 33903902. doi:10.1093/infdis/jiab224

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。